- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Metastatic Castration-resistant Prostate Cancer in New Zealand
Total 2045 results
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
858 Therapeutics, Inc.RecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Ovarian Cancer | Prostate Cancer | Endometrial Cancer | Epithelial Ovarian Cancer | BRCA1 Mutation | BRCA2 Mutation | Advanced or Metastatic Solid Tumors | ER+ Breast Cancer | Castrate Resistant Prostate Cancer | BRCA MutationUnited States
-
ProteoMediX AGCompletedIndication for Prostate Biopsy Due to Suspected Prostate CancerAustria, Germany, Denmark
-
Ascenta TherapeuticsCompletedHormone Refractory Prostate CancerUnited States, Russian Federation
-
NRG OncologyNational Cancer Institute (NCI)RecruitingProstate Adenocarcinoma | Stage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer... and other conditionsUnited States
-
Ashutosh Kumar TewariOncovir, Inc.RecruitingProstate Cancer Patients on Active SurveillanceUnited States
-
Catherine SpinaArcus Biosciences, Inc.RecruitingOligometastatic Prostate CancerUnited States
-
Eli Lilly and CompanyCompleted
-
SpectraCure ABRecruitingRecurrent Prostate CancerUnited States, Canada, United Kingdom, Sweden
-
Genta IncorporatedUnknownProstate CancerUnited States
-
Oxford BioMedicaMedSource LLCTerminatedHormone Refractory Prostate CancerUnited States
-
RPCR, Inc.UnknownProstate Cancer Early Risk Treated by Radiosurgery | Prostate Cancer Intermediate Risk Treated by RadiosurgeryUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Prostate Carcinoma | Stage IIA Prostate Cancer AJCC v7 | Stage III Prostate Cancer AJCC v7 | Stage I Prostate Cancer AJCC v7 | Stage IIB Prostate Cancer AJCC v7United States, Ireland
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyTerminated
-
Sapience TherapeuticsRecruitingBreast Cancer | Glioblastoma | Prostate Cancer | Brain Cancer | Glioblastoma Multiforme | GBM | Metastatic Breast Cancer | Recurrent Glioblastoma | Metastatic Melanoma | Metastatic Prostate Cancer | Prostate Cancer Metastatic | Newly Diagnosed Glioblastoma | Melanoma Stage IV | Melanoma RecurrentUnited States, United Kingdom
-
Fox Chase Cancer CenterNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Philips HealthcareWithdrawnProstate CancerUnited States
-
National Cancer Institute (NCI)CompletedProstate CancerUnited States
-
PfizerRecruitingSmall Cell Lung Cancer (SCLC) | Follicular Lymphoma (FL) | Castration Resistant Prostate Cancer (CRPC)United States, Spain, Korea, Republic of, Poland, China, Bulgaria, Russian Federation, Japan
-
Boston Scientific CorporationSuspendedCancer | ProstateUnited States
-
Celgene CorporationPrologue Research InternationalTerminated
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Howard University; Prostate Cancer Clinical Trials ConsortiumCompleted
-
PROCEPT BioRoboticsRecruitingLocalized Prostate CancerUnited States
-
NRG OncologyNational Cancer Institute (NCI)SuspendedProstate Adenocarcinoma | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8Canada, United States
-
Steba Biotech S.A.Active, not recruitingLocalized Prostate CancerUnited States
-
ExelixisActive, not recruitingA Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors (STELLAR-001)Renal Cell Carcinoma | Colorectal Cancer | Metastatic Castration-resistant Prostate Cancer | Hormone Receptor Positive Breast Carcinoma | Neoplasm MalignantUnited States, Australia, Belgium, Czechia, France, Germany, Italy, Netherlands, Spain, United Kingdom
-
Janssen Research & Development, LLCRecruitingAdvanced Prostate CancerFrance, United States
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.Completed
-
Weill Medical College of Cornell UniversityCancer Research & Treatment Fund, IncTerminatedProstate CancerUnited States
-
Ashutosh Kumar TewariOncovir, Inc.Completed
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Memorial Sloan Kettering Cancer CenterCompletedProstate CancerUnited States
-
William K. OhProstate Cancer FoundationCompleted
-
NYU Langone HealthCompletedProstate CancerUnited States
-
Rockefeller UniversityMemorial Sloan Kettering Cancer CenterCompleted
-
Molecular Insight Pharmaceuticals, Inc.Completed
-
Molecular Insight Pharmaceuticals, Inc.Completed
-
AstraZenecaCompletedProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Institutes of Health (NIH)Completed
-
Memorial Sloan Kettering Cancer CenterAmbrilia Biopharma, Inc.CompletedProstate CancerUnited States
-
Xanthus Pharmaceuticals, Inc.Completed
-
National Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Columbia UniversityBristol-Myers Squibb; Ferring PharmaceuticalsActive, not recruiting
-
NYU Langone HealthTerminated
-
NYU Langone HealthCompleted
-
Weill Medical College of Cornell UniversityCompleted
-
Weill Medical College of Cornell UniversityCompleted
-
Memorial Sloan Kettering Cancer CenterCompleted